Journal

Introduction — The Microbiota as a Fully-Fledged Metabolic and Immune Organ

The gut microbiota can no longer be viewed as a mere digestive aid. Findings from microbiology, immunology and metabolic physiology now describe it as a true functional organ, composed of thousands of bacterial, viral and fungal species, capable of producing bioactive metabolites, engaging in constant dialogue with the immune system, and profoundly modulating the host’s energy metabolism [1–3].

Its influence extends far beyond digestion. The gut microbiota plays a central role in the regulation of inflammation, immune efficiency, body-weight control, insulin sensitivity, and even in the subjective perception of energy and fatigue [4–6]. Any persistent disruption of this ecosystem — known as dysbiosis — can therefore become a major driver of systemic biological imbalance.

Chapter I — Microbiota, Energy and Metabolism: A Key Interface of Cellular Efficiency

I.1. Food Substrate Transformation and Indirect Energy Production

The gut microbiota plays a critical role in extracting energy from the diet. Dietary fibres that cannot be digested by human enzymes are fermented by specific intestinal bacteria into short-chain fatty acids (SCFAs) — mainly acetate, propionate and butyrate [7].

These SCFAs act as:

• a direct energy source for colonocytes (particularly butyrate),
• modulators of hepatic and muscular metabolism,
• hormonal signalling molecules influencing satiety, insulin sensitivity and energy expenditure [8–10].

Dysbiosis reduces this fermentative capacity, leading to diminished metabolic efficiency, functional chronic fatigue and dysregulation of glucose and lipid metabolism.

I.2. Microbiota, Mitochondria and Low-Grade Inflammation

Microbial metabolites interact directly with mitochondrial function. A balanced microbiota supports efficient cellular energy production, whereas dysbiosis increases intestinal permeability and systemic exposure to lipopolysaccharides (LPS) [11].

This state of low-grade metabolic endotoxaemia sustains silent chronic inflammation, impairing insulin signalling, mitochondrial performance and the organism’s adaptive capacity [12–14]. Energy levels decline not because of insufficient calories, but due to biological inefficiency.

Chapter II — Microbiota and Immunity: A System of Continuous Immune Training

II.1. Immune Education and Tolerance

Approximately 70% of immune cells reside within the gut-associated lymphoid tissue (GALT). The gut microbiota actively contributes to immune maturation, regulatory T-cell differentiation, and the balance between immune tolerance and defence [15–17].

A diverse and stable microbiota:

• strengthens the intestinal barrier,
• limits excessive inflammatory responses,
• promotes effective yet well-regulated immunity.

Conversely, dysbiosis is associated with recurrent infections, allergies, autoimmune conditions and chronic inflammation [18–20].

II.2. Systemic Inflammation and Immune Dysregulation

When the intestinal ecosystem is compromised, gut permeability increases. Bacterial fragments can then enter systemic circulation, inappropriately activating innate immune responses [21].

This chronic immune activation diverts immune resources, weakens effective pathogen defence, and fosters an inflammatory environment that is detrimental to metabolic health and weight regulation.

Chapter III — Microbiota, Body Weight and Food Supplements: Restoring a Favourable Biological Terrain

III.1. Microbiota and Body-Weight Regulation

Comparative studies between lean and obese individuals reveal significant differences in microbiota composition, diversity and metabolic function [22–24]. Certain microbial profiles promote:

• excessive energy extraction from food,
• metabolic inflammation,
• leptin and insulin resistance.

Body weight is therefore not solely a matter of calorie balance, but of the microbiota–metabolism–immunity axis.

III.2. The Strategic Role of Food Supplements in Modulating the Microbiota

Diet remains the foundation of gut-ecosystem health. However, in modern contexts characterised by chronic stress, medication use, fibre-poor diets and low-grade inflammation, diet alone may be insufficient to restore functional microbial balance.

Targeted food supplements can then:

• provide clinically documented probiotic strains,
• support bacterial diversity,
• foster an intestinal environment compatible with immune and metabolic health.

III.3. Focus — N°4 FLORA (METHODE ESPINASSE): Cellular Nutrition® Applied to the Microbiota

N°4 FLORA is designed within a Cellular Nutrition® framework, recognising the microbiota as a central lever of global biological coherence.

Its formulation aims to:

• support intestinal flora balance,
• reinforce the gut barrier,
• modulate low-grade inflammation,
• create a biological terrain favourable to metabolic energy and immune resilience.

The objective is not to “force” the microbiota, but to restore the biological conditions that allow the intestinal ecosystem to function autonomously, stably and resiliently, in alignment with the organism’s cellular needs.

This systemic approach explains why microbiota-targeted interventions can exert cross-functional benefits on vitality, weight regulation and immune robustness — without relying on stimulatory or isolated corrective mechanisms.

Conclusion — The Microbiota as a Cornerstone of Global Health

The gut microbiota now stands as one of the most decisive determinants of human health. Its influence on energy, immunity and body weight highlights a fundamental biological reality: health is not the sum of isolated functions, but the coherence of an integrated system.

Acting on the microbiota — through diet and through supplements designed within a cellular and functional framework — represents one of the most powerful and sustainable levers of modern prevention and physiological balance restoration.

Bibliography

[1] Belkaid Y., Hand T.W. (2014). Role of the microbiota in immunity and inflammation. Cell.
https://www.cell.com/cell/fulltext/S0092-8674(14)00222-0

[2] Sommer F., Bäckhed F. (2013). The gut microbiota — masters of host development and physiology. Nature Reviews Microbiology.
https://www.nature.com/articles/nrmicro2974

[3] Turnbaugh P.J. et al. (2007). The human microbiome project. Nature.
https://www.nature.com/articles/nature06244

[4] Tilg H., Moschen A.R. (2014). Microbiota and inflammation. Nature Reviews Immunology.
https://www.nature.com/articles/nri3740

[5] Hotamisligil G.S. (2017). Inflammation, metaflammation and immunometabolic disorders. Immunity.
https://www.cell.com/immunity/fulltext/S1074-7613(17)30024-7

[6] Nicholson J.K. et al. (2012). Host-gut microbiota metabolic interactions. Nature Biotechnology.
https://www.nature.com/articles/nbt.2089

[7] Koh A. et al. (2016). From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell.
https://www.cell.com/cell/fulltext/S0092-8674(16)30895-0

[8] Canfora E.E., Meex R.C.R., Venema K., Blaak E.E. (2019). Gut microbial metabolites in obesity, NAFLD and T2DM. Nature Reviews Endocrinology.
https://www.nature.com/articles/s41574-019-0156-z

[9] den Besten G. et al. (2013). The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research.
https://www.jlr.org/article/S0022-2275(20)33663-4/fulltext

[10] Chambers E.S. et al. (2018). Effects of targeted delivery of propionate to the colon on appetite regulation. Gut.
https://gut.bmj.com/content/67/2/308

[11] Cani P.D. et al. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes.
https://diabetesjournals.org/diabetes/article/56/7/1761/14596

[12] Furman D. et al. (2019). Chronic inflammation in the etiology of disease across the life span. Nature Medicine.
https://www.nature.com/articles/s41591-019-0675-0

[13] Franceschi C. et al. (2018). Inflammaging and “Garb-aging”. Nature Reviews Endocrinology.
https://www.nature.com/articles/s41574-018-0059-4

[14] Hotamisligil G.S. (2006). Inflammation and metabolic disorders. Nature.
https://www.nature.com/articles/nature05485

[15] Round J.L., Mazmanian S.K. (2009). The gut microbiota shapes intestinal immune responses. Nature Reviews Immunology.
https://www.nature.com/articles/nri2515

[16] Hooper L.V. et al. (2012). Interactions between the microbiota and the immune system. Science.
https://www.science.org/doi/10.1126/science.1223490

[17] Honda K., Littman D.R. (2016). The microbiota in adaptive immune homeostasis and disease. Cell.
https://www.cell.com/cell/fulltext/S0092-8674(16)30079-6

[18] Vatanen T. et al. (2016). Variation in microbiome LPS immunogenicity contributes to autoimmunity. Cell.
https://www.cell.com/cell/fulltext/S0092-8674(16)30198-6

[19] Tilg H., Zmora N., Adolph T.E., Elinav E. (2020). The intestinal microbiota fuelling metabolic inflammation. Gut.
https://gut.bmj.com/content/69/5/858

[20] Belkaid Y., Harrison O.J. (2017). Homeostatic immunity and the microbiota. Immunity.
https://www.cell.com/immunity/fulltext/S1074-7613(17)30078-8

[21] Mu Q. et al. (2017). Gut microbiota: the brain peacekeeper. Frontiers in Immunology.
https://www.frontiersin.org/articles/10.3389/fimmu.2017.00010/full

[22] Turnbaugh P.J. et al. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature.
https://www.nature.com/articles/nature05414

[23] Ley R.E. et al. (2006). Microbial ecology: human gut microbes associated with obesity. Nature.
https://www.nature.com/articles/4441022a

[24] Gérard P. (2016). Gut microbiota and obesity. Current Opinion in Clinical Nutrition and Metabolic Care.
https://journals.lww.com/co-clinicalnutrition/Fulltext/2016/07000/Gut_microbiota_and_obesity.9.aspx